Affiliation:
1. Nanjing University of Chinese Medicine
2. Suzhou TCM Hospital, Nanjing University of Chinese Medicine
3. Anhui University of Chinese Medicine
Abstract
Abstract
Background
In the context of the development of Intervertebral Disc Degeneration (IDD), inflammatory mediators play a pivotal role. Nevertheless, due to the influence of the inflammatory microenvironment, the causal relationship between specific inflammatory mediators and the development of IDD remains uncertain.
Methods
We utilized genetic data concerning systemic circulating inflammatory regulators obtained from a Genome-Wide Association Study (GWAS) analyzing 41 serum cytokines in a cohort of 8,293 individuals from Finland. The genetic data for IDD was derived from the most recent Genome-Wide Association Study summary statistics conducted within the FinnGen consortium, encompassing 37,636 IDD cases and 270,964 controls. Our analysis employed bidirectional two-sample Mendelian randomization (MR) techniques, which included several MR methods such as MR Egger, weighted median, inverse variance weighted (IVW), weighted mode, and simple mode. Additionally, the MR-PRESSO method was employed to identify horizontal pleiotropy, heterogeneity was quantified using the Cochran Q statistic, and MR Egger intercept analysis was performed to assess pleiotropy.
Results
We established causal relationships between three specific inflammatory factors and IDD. Elevated levels of MIP-1β [OR = 0.956, 95% CI: -0.08 to -0.006; P = 0.02] and IFN-G [OR = 0.915, 95% CI: -0.16 to -0.02; P = 0.01] expression were associated with a reduced risk of IDD. Conversely, genetic susceptibility to IDD was linked to a decrease in IL13 levels [OR = 0.967, 95% CI: -0.063 to -0.004; P = 0.03].
Conclusion
In this study, we have identified inflammatory factors that exhibit a causal relationship with the onset and progression of IDD, as supported by genetic predictions.
Publisher
Research Square Platform LLC
Reference39 articles.
1. GBD Disease I Injury C Prevalence. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858. https://doi.org/10.1016/S0140-6736(18)32279-7.
2. Notochordal cells: A potential therapeutic option for intervertebral disc degeneration;Li Y;Cell Prolif. 2023 Sep
3. Lipid metabolism disorder promotes the development of intervertebral disc degeneration;Yi J;Biomed Pharmacother,2023
4. Inflammatory mediators in intervertebral disk degeneration and discogenic pain;Wuertz K;Global Spine J,2013
5. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration;Maitre CL;Arthritis Res Ther,2005